At this time, the thoughts of all those involved in the EHDEN project are with those ill with COVID-19, and those who are looking after them at home or in hospitals.
Clearly, we are all affected by this evolving pandemic, and equally, the project will be impacted by it, but we will aim to mitigate this as best as practicable.
We are looking forward to working with our Data Partners and colleagues in responding to COVID-19.
Our best wishes to all, stay safe and well.
Welcome to the website of the European Health Data & Evidence Network (EHDEN), an IMI 2 consortium with 22 partners which will operate in Europe for the coming five years, 2018 – 2024.
EHDEN was launched to address the current challenges in generating insights and evidence from real-world clinical data at scale, to support patients, clinicians, payers, regulators, governments, and the pharmaceutical industry in understanding wellbeing, disease, treatments, outcomes and new therapeutics and devices.
EHDEN’s COVID-19 Rapid Collaboration Call – Paving the way to generate real-world evidence and treatment insights
19 May, 2020, Brussels, Belgium: Clinicians, scientists, governments and the public all want to...
The world is still very much fighting the SARS-CoV- 2 pandemic, and in many...
Brussels, Belgium, 23 April, 2020: The European Health Data & Evidence Network (EHDEN) today...
We are excited to announce that the EHDEN Academy will launch publicly on Thursday,...